health π FDA clears first mRNA flu shot for seniors
The FDA approved Moderna's first mRNA-based flu vaccine for older adults. This vaccine is targeted at people aged 50 and over in the US. It was given standard approval for ages 50-64 and accelerated approval for those 65 and older. The mRNA tech allows for faster strain matching compared to traditional manufacturing methods. The vaccine showed about 27% higher effectiveness than standard shots in a study of over 40,000 people. π